Release Date: 21/11/08 08:26 Summary: FURTHER EXCELLENT RESULTS FROM THUNDER BAY NORTH Price Sensitive: Yes Download Document 686.07KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%